Skip to main content

Table 4 Quality of life at each time points: IMRT vs. VMAT

From: Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy

 

IMRT: VMAT

ti1

ti2

ti3

ti4

Patient number

74: 66

72: 65

69: 61

55: 49

EORTC QLQ-C30

 Global quality of life

54: 55

34: 40

57: 60

67: 66

 Physical functioning

91: 94

81: 80

86: 87

92: 90

 Role functioning

77: 75

68: 65

78: 76

86: 87

 Emotional functioning

91: 93

73: 72

89: 87

96: 92

 Cognitive functioning

79: 73

75: 74

85: 82

86: 87

 Social functioning

84: 87

77: 80

84: 85

87: 83

 Fatigue

19: 22

42: 48

29: 29

20: 25

 Nausea/Vomiting

7: 7

42: 40

10: 9

5: 2

 Pain

13: 16

38: 35

17: 14

13: 15

 Dyspnea

9: 4

13: 13

11: 6

7: 3

 Insomnia

21: 25

28: 34

19: 25

19: 24

 Appetite loss

13: 13

59: 59

27: 22

12: 9

 Constipation

13: 11

25: 23

16: 19

13: 15

 Diarrhea

8: 12

14: 15

9: 9

8: 5

 Financial difficulties

25: 24

28: 25

22: 25

17: 12

EORTC QLQ-HN35

 Pain

7: 5

38: 35

15: 15

10: 7

 Swallowing

7: 5

44: 40

20: 18

14: 15

 Senses (taste/smell)

7: 6

46: 50

27: 24

16: 14

 Speech

7: 4

20: 18

17: 14

11: 7

 Social eating

5: 2

46: 42

20: 20

10: 13

 Social contact

4: 3

20: 17

11: 10

5: 5

 Sexuality

14: 17

39: 42

23: 27

16: 22

 Teeth

18: 22

28: 31

23: 27

25: 28

 Opening mouth

5: 3

18: 14

14: 13

12: 15

 Dry mouth

18: 2 1

59: 57

53: 51

44: 46

 Sticky saliva

15: 16

55: 58

39: 3 9

30: 27

 Coughing

20: 18

21: 24

22: 21

18: 23

 Feeling ill

23: 16

50: 54

27: 28

17: 18

  1. IMRT Intensity modulated radiotherapy, VMAT Volumetric modulated arc therapy; ti1 = before RT; ti2: RT 42.4 Gy; ti3: 3 months after RT; ti4: 12 months after RT.